Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature
Joint Authors
Kharel, Prakash
Uprety, Deekchha
Chandra, Abhinav B.
Hu, Yirui
Belur, Anuradha Avinash
Dhakal, Ajay
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-11-25
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma.
Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports.
The objective of this study is to report a case of bortezomib-induced lung injury, review current literature, and perform exploratory analysis.
American Psychological Association (APA)
Kharel, Prakash& Uprety, Deekchha& Chandra, Abhinav B.& Hu, Yirui& Belur, Anuradha Avinash& Dhakal, Ajay. 2018. Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature. Case Reports in Medicine،Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1144828
Modern Language Association (MLA)
Kharel, Prakash…[et al.]. Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature. Case Reports in Medicine No. 2018 (2018), pp.1-5.
https://search.emarefa.net/detail/BIM-1144828
American Medical Association (AMA)
Kharel, Prakash& Uprety, Deekchha& Chandra, Abhinav B.& Hu, Yirui& Belur, Anuradha Avinash& Dhakal, Ajay. Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature. Case Reports in Medicine. 2018. Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1144828
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1144828
